Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 52.81%-8.41M | ---- | 32.12%-17.82M | ---- | 66.53%-26.26M | ---- | -5.05%-78.44M | ---- | -10.89%-74.67M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -120.99%-1.03M | ---- | 32.71%-467K | ---- | -638.30%-694K | ---- | -113.64%-94K | ---- | 38.89%-44K |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -17.05%-508K | ---- | ---434K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -76.92%3K | ---- | 62.50%13K |
| Impairment and provisions: | ---- | ---- | ---- | -96.50%86K | ---- | 5,220.83%2.46M | ---- | 95.58%-48K | ---- | -164.13%-1.09M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | -199.65%-565K | ---- | -28.14%567K | ---- | 208.20%789K | ---- | 127.77%256K |
| -Other impairments and provisions | ---- | ---- | ---- | -65.57%651K | ---- | 325.93%1.89M | ---- | 37.58%-837K | ---- | -151.30%-1.34M |
| Revaluation surplus: | ---- | ---- | ---- | -98.33%124K | ---- | -88.17%7.42M | ---- | 11.63%62.76M | ---- | 22.14%56.22M |
| -Other fair value changes | ---- | ---- | ---- | -98.33%124K | ---- | -88.17%7.42M | ---- | 11.63%62.76M | ---- | 22.14%56.22M |
| Asset sale loss (gain): | ---- | ---6.6M | ---- | ---- | ---- | 109.99%213K | ---- | -183.64%-2.13M | ---- | 75.51%-752K |
| -Available for sale investment sale loss (gain) | ---- | ---6.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 64.33%-815K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | 100.19%4K | ---- | -3,485.71%-2.13M | ---- | 108.02%63K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | --209K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -12.69%1.46M | ---- | 9.22%1.67M | ---- | 30.99%1.53M | ---- | -7.08%1.17M | ---- | -58.64%1.26M |
| Financial expense | ---- | 1.75%58K | ---- | -20.83%57K | ---- | -7.69%72K | ---- | -78.09%78K | ---- | -62.17%356K |
| Special items | ---- | 2,403.77%1.33M | ---- | -15.87%53K | ---- | 157.27%63K | ---- | ---110K | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 19.03%-13.2M | ---- | -7.27%-16.3M | ---- | 12.31%-15.19M | ---- | 9.48%-17.33M | ---- | -1.98%-19.14M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 125.94%523K | ---- | 77.33%-2.02M | ---- | -147.81%-8.89M | ---- | 713.90%18.6M | ---- | -123.00%-3.03M |
| Accounts receivable (increase)decrease | ---- | 100.98%102K | ---- | -1,611.17%-10.42M | ---- | -101.17%-609K | ---- | 74.01%52.11M | ---- | 194.60%29.95M |
| Accounts payable increase (decrease) | ---- | -3,760.87%-842K | ---- | -98.83%23K | ---- | 111.72%1.96M | ---- | -737.11%-16.74M | ---- | 128.43%2.63M |
| prepayments (increase)decrease | ---- | -88.27%472K | ---- | 159.12%4.03M | ---- | -467.40%-6.81M | ---- | -66.47%1.85M | ---- | 198.93%5.53M |
| Cash from business operations | ---- | 47.57%-12.94M | ---- | 16.43%-24.69M | ---- | -176.75%-29.54M | ---- | 141.64%38.49M | ---- | 130.51%15.93M |
| Other taxs | ---- | 11.76%-45K | ---- | -363.64%-51K | ---- | 68.57%-11K | ---- | -163.64%-35K | ---- | 136.91%55K |
| Interest paid - operating | ---- | -1.75%-58K | ---- | 20.83%-57K | ---- | 12.20%-72K | ---- | 92.52%-82K | ---- | -456.35%-1.1M |
| Special items of business | 4.08%-10.09M | ---- | 39.79%-10.52M | ---- | -121.78%-17.47M | ---- | -123.74%-7.88M | ---- | -10.82%33.19M | ---- |
| Net cash from operations | 4.08%-10.09M | 47.39%-13.05M | 39.79%-10.52M | 16.30%-24.8M | -121.78%-17.47M | -177.20%-29.62M | -123.74%-7.88M | 157.75%38.37M | -10.82%33.19M | 128.33%14.89M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 50.00%228K | 120.99%1.03M | 24.59%152K | -32.71%467K | -27.38%122K | 638.30%694K | 572.00%168K | 113.64%94K | 31.58%25K | -38.89%44K |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 17.05%508K | 17.05%508K | --434K |
| Sale of fixed assets | --1K | ---- | ---- | ---- | ---- | -99.86%3K | --3K | --2.09M | ---- | ---- |
| Purchase of fixed assets | ---- | ---- | ---- | -15.61%-437K | -65.53%-437K | 74.30%-378K | -725.00%-264K | -1,630.59%-1.47M | 54.29%-32K | 97.71%-85K |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | --225K | --225K | ---- | ---- | ---- |
| Purchase of intangible assets | ---15.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 235.96%2.98M |
| Recovery of cash from investments | --19.56M | --13.88M | ---- | ---- | ---- | -94.87%792K | -94.87%792K | --15.44M | --15.44M | ---- |
| Cash on investment | ---- | ---207K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 2,590.79%4.09M | 48,900.00%14.7M | 148.25%152K | -97.75%30K | -134.09%-315K | -91.98%1.34M | -94.20%924K | 393.80%16.66M | 4,061.36%15.94M | 101.68%3.37M |
| Net cash before financing | 42.12%-6M | 106.68%1.65M | 41.71%-10.37M | 12.45%-24.77M | -155.77%-17.79M | -151.40%-28.29M | -114.16%-6.96M | 201.35%55.03M | 30.66%49.13M | 107.22%18.26M |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,162.60%-9.92M |
| Interest paid - financing | ---- | --58K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.45M | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | 118.37%450K | ---- | ---2.45M | ---- | ---- |
| Net cash from financing operations | 7.71%-359K | -5.73%-756K | -16.47%-389K | -528.14%-715K | -307.32%-334K | 127.56%167K | 23.36%-82K | 94.05%-606K | 98.94%-107K | -204.40%-10.19M |
| Effect of rate | 479.55%255K | -30.92%-1.01M | 105.09%44K | 62.55%-773K | 70.43%-864K | -272.58%-2.06M | -944.51%-2.92M | -2.13%1.2M | -54.35%346K | 840.00%1.22M |
| Net Cash | 40.87%-6.36M | 103.52%898K | 40.64%-10.76M | 9.39%-25.48M | -157.54%-18.12M | -151.67%-28.12M | -114.36%-7.04M | 573.90%54.42M | 77.92%49.02M | 103.32%8.08M |
| Begining period cash | -0.31%36.28M | -41.91%36.39M | -41.91%36.39M | -32.52%62.65M | -32.52%62.65M | 149.46%92.83M | 149.46%92.83M | 33.31%37.21M | 33.31%37.21M | -89.69%27.92M |
| Cash at the end | 17.50%30.17M | -0.31%36.28M | -41.18%25.68M | -41.91%36.39M | -47.32%43.66M | -32.52%62.65M | -4.28%82.87M | 149.46%92.83M | 53.99%86.58M | 33.31%37.21M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.